Title : E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptor.

Pub. Date : 2011 Jul

PMID : 21551260






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We have assessed the therapeutic efficacy of E7080, an orally available inhibitor of multiple tyrosine kinases including VEGF receptor 2 (VEGFR-2) and VEGFR-3, in experimental multiple organ metastasis of lung cancer cell lines without EGFR mutations. lenvatinib epidermal growth factor receptor Homo sapiens